-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Ptc Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2023.
- Ptc Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $19.8M, a 26.7% decline year-over-year.
- Ptc Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $73.9M, a 34.3% decline year-over-year.
- Ptc Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $102M, a 7.88% decline from 2022.
- Ptc Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $110M, a 6.59% increase from 2021.
- Ptc Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $104M, a 47.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)